Mark Nance, chief legal officer and general counsel of the troubled drug company Insys Therapeutics Inc., plans to resign from the company July 31, apparently giving up a $613,000 retention bonus.
Nance, who could not be reached for comment Tuesday, joined the company last October as a member of its senior management team. At the time the Phoenix-based pharma company was facing criminal and False Claims Act allegations that it bribed doctors to prescribe one of its popular opioid drugs, Subsys.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]